nach oben

Breast Cancer Research and Treatment

Erschienen in:

01.11.2013 | Epidemiology

Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: Are there differences before and after age 40?

verfasst von: Erica T. Warner, Graham A. Colditz, Julie R. Palmer, Ann H. Partridge, Bernard A. Rosner, Rulla M. Tamimi

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

We examined the relationship between reproductive factors and risk of premenopausal breast cancer among women less than age 40 compared with older premenopausal women. We documented 374 incident cases of breast cancer diagnosed before age 40, and 2,533 cases diagnosed at age 40 and older among premenopausal women in the Nurses’ Health Study cohorts. Biennial questionnaires were used to determine age at menarche, age at first birth, parity, breastfeeding, and other reproductive factors. Multivariate relative risks (RR) and 95 % confidence intervals (CI) were calculated using Cox proportional hazards models within age at diagnosis groups. Tumors in younger women were significantly more likely to be higher grade, larger size, and hormone receptor negative than were tumors in older premenopausal women (p < 0.0001). There was no significant heterogeneity according to age in associations between reproductive factors and risk of premenopausal breast cancer. First birth at age 30 or older increased breast cancer risk in both age groups (age <40: RR 1.10, 95 % CI 0.80–1.50; age ≥40: RR 1.16, 95 % CI 1.02–1.32; p-heterogeneity = 0.44). Risk of premenopausal breast cancer decreased with each additional year of age at menarche in both age groups (age <40: RR 0.93, 95 % CI 0.87–0.99; p trend = 0.02; age ≥40: RR 0.94, 95 % CI 0.91–0.97; p trend = <0.0001). Among premenopausal parous women, breastfeeding was protective regardless of age at diagnosis (age <40: RR 0.84, 95 % CI 0.57–1.22; age ≥40: RR 0.85, 95 % CI 0.72–0.99; p-heterogeneity = 0.79). In the largest prospective examination of reproductive risk factors and risk of breast cancer before and after age 40, we found that younger women were more likely to develop tumors with less favorable prognostic characteristics. However, associations between reproductive factors and risk of breast cancer were similar regardless of age at diagnosis of premenopausal breast cancer.

Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30PubMedCrossRef

Yankaskas BC (2006) Epidemiology of breast cancer in young women. Breast Dis 23:3–8

Anders CK, Johnson R, Litton J et al (2009) Breast cancer before age 40 Years. Semin Oncol 36:237–249PubMedCrossRef

Tarone RE (2006) Breast cancer trends among young women in the United States. Epidemiology 17:588–590PubMedCrossRef

Clarke CA, Glaser SL (2007) Declines in breast cancer after the WHI: apparent impact of hormone therapy. Cancer Causes Control 18:847–852PubMedCrossRef

Johnson RH, Chien FL, Bleyer A (2013) Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA 309:800–805PubMedCrossRef

Tavani A, Gallus S, La Vecchia C et al (1999) Risk factors for breast cancer in women under 40 years. Eur J Cancer 35:1361–1367PubMedCrossRef

Michels KB, Terry KL, Willett WC (2006) Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 166:2395–2402PubMedCrossRef

Terry KL, Willett WC, Rich-Edwards JW et al (2005) Menstrual cycle characteristics and incidence of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14:1509–1513PubMedCrossRef

10.

Berstad P, Ma H, Bernstein L et al (2008) Alcohol intake and breast cancer risk among young women. Breast Cancer Res Treat 108:113–120PubMedCrossRef

11.

Chan A, Pintilie M, Vallis K et al (2000) Breast cancer in women < or = 35 years: review of 1002 cases from a single institution. Ann Oncol 11:1255–1262PubMedCrossRef

12.

Gligorov J, Guilhaume M, Spielmann M et al (2005) Breast cancer in young women age <36 years: a retrospective analysis of prognostic factors in 926 patients in 8 french instituitions. GETNA group. J Clin Oncol 23:9685

13.

Nyante SJ, Gammon MD, Malone KE et al (2008) The association between oral contraceptive use and lobular and ductal breast cancer in young women. Int J Cancer 122:936–941PubMedCrossRef

14.

Palmer JR, Wise LA, Horton NJ et al (2003) Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst 95:478–483PubMedCrossRef

15.

Yankaskas BC (2005) Epidemiology of breast cancer in young women. Breast Dis 23:3–8PubMed

16.

Zabicki K, Colbert JA, Dominguez FJ et al (2006) Breast cancer diagnosis in women < or = 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Ann Surg Oncol 13:1072–1077PubMedCrossRef

17.

Jatoi I, Chen BE, Anderson WF et al (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25:1683PubMedCrossRef

18.

Althuis MD, Brogan DD, Coates RJ et al (2003) Breast cancers among very young premenopausal women (United States). Cancer Causes Control 14:151–160PubMedCrossRef

19.

Anderson WF, Matsuno RK, Sherman ME et al (2007) Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control 18:439–447PubMedCrossRef

20.

Peppercorn J, Partridge AH (2008) Breast cancer in young women: a new color or a different shade of pink? J Clin Oncol 26:3303–3305PubMedCrossRef

21.

Pollán M (2010) Epidemiology of breast cancer in young women. Breast Cancer Res Treat 123:3–6PubMedCrossRef

22.

Collins L, Marotti J, Gelber S et al (2012) Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 131:1061–1066PubMedCrossRef

23.

Klauber-DeMore N (2006) Tumor biology of breast cancer in young women. Breast Dis 23:9–15

24.

Ahn SH, Son BH, Kim SW et al (2007) Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea—a report from the Korean breast cancer society. J Clin Oncol 25:2360–2368PubMedCrossRef

25.

Anders CK, Hsu DS, Broadwater G et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324PubMedCrossRef

26.

Bertheau P, Steinberg SM, Merino MJ (1998) C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation. Hum Pathol 29:323–329PubMedCrossRef

27.

Keegan TH, DeRouen MC, Press DJ et al (2012) Occurrence of breast cancer subtypes in adolescent and young adult women. Breast Cancer Res 14:R55PubMedCrossRef

28.

Axelrod D, Smith J, Kornreich D et al (2008) Breast cancer in young women. J Am Coll Surg 206:1193–1203PubMedCrossRef

29.

Anders CK, Acharya CR, Hsu DS et al (2008) Age-specific differences in oncogenic pathway deregulation seen in human breast tumors. PLoS One 3(1):e1373PubMedCrossRef

30.

Anders CK, Fan C, Parker JS et al (2011) Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol 29:e18–e20PubMedCrossRef

31.

Azim HA, Michiels S, Bedard PL et al (2012) Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res 18:1341–1351PubMedCrossRef

32.

Fredholm H, Eaker S, Frisell J et al (2009) Breast cancer in young women: poor survival despite intensive treatment. PLoS One 4:e7695PubMedCrossRef

33.

El Saghir NS, Seoud M, Khalil MK et al (2006) Effects of young age at presentation on survival in breast cancer. BMC Cancer 6:194PubMedCrossRef

34.

Partridge AH, Gelber S, Piccart-Gebhart MJ et al (2013) Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2–positive breast cancer: results from a herceptin adjuvant trial. J Clin Oncol 31(21):2692–2698PubMedCrossRef

35.

Yau C, Wang Y, Zhang Y et al (2011) Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers. Breast Cancer Res Treat 126:803–810PubMedCrossRef

36.

Rosner B, Colditz GA, Willett WC (1994) Reproductive risk factors in a prospective study of breast cancer: the nurses’ health study. Am J Epidemiol 139:819–835PubMed

37.

Yang XR, Sherman ME, Rimm DL et al (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 16:439–443PubMedCrossRef

38.

Ursin G, Bernstein L, Lord SJ et al (2005) Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 93:364–371PubMedCrossRef

39.

Colditz GA, Rosner BA, Chen WY et al (2004) Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 96:218–228PubMedCrossRef

40.

Althuis MD, Fergenbaum JH, Garcia-Closas M et al (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13:1558–1568PubMed

41.

Colditz GA, Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the nurses’ health study. Am J Epidemiol 152:950–964PubMedCrossRef

42.

Pathak DR (2002) Dual effect of first full term pregnancy on breast cancer risk: empirical evidence and postulated underlying biology. Cancer Causes Control 13:295–298PubMedCrossRef

43.

Pathak DR, Speizer FE, Willett WC et al (2006) Parity and breast cancer risk: possible effect on age at diagnosis. Int J Cancer 37:21–25CrossRef

44.

Colditz GA, Hankinson SE (2005) The nurses’ health study: lifestyle and health among women. Nat Rev Cancer 5:388–396PubMedCrossRef

45.

Glynn RJ, Rosner B (2005) Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 162:975–982PubMedCrossRef

46.

Glynn RJ, Rosner B, Christen WG (2009) Evaluation of risk factors for cataract types in a competing risks framework. Ophthalmic Epidemiol 16:98–106PubMedCrossRef

47.

Lunn M, McNeil D (1995) Applying Cox regression to competing risks. Biometrics 51:524–532PubMedCrossRef

48.

Palmer JR, Boggs DA, Wise LA et al (2011) Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev 20:1883–1891PubMedCrossRef

49.

Phipps AI, Chlebowski RT, Prentice R et al (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 103:470–477PubMedCrossRef

50.

Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103:250–263PubMedCrossRef

51.

Setiawan VW, Monroe KR, Wilkens LR et al (2009) Breast cancer risk factors defined by estrogen and progesterone receptor status. Am J Epidemiol 169:1251–1259PubMedCrossRef

52.

Millikan RC, Newman B, Tse CK et al (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123–139PubMedCrossRef

53.

Li CI, Beaber EF, Tang MC et al (2013) Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age. Breast Cancer Res Treat 137:579–587PubMedCrossRef

54.

Redondo CM, Gago-Domínguez M, Ponte SM et al (2012) Breast feeding, parity and breast cancer subtypes in a Spanish cohort. PLoS One 7:e40543PubMedCrossRef

55.

Colditz GA, Kaphingst KA, Hankinson SE et al (2012) Family history and risk of breast cancer: nurses’ health study. Breast Cancer Res Treat 133:1097–1104PubMedCrossRef

56.

Ellis D, Greenman J, Hodgson S et al (2000) Low prevalence of germline BRCA1 mutations in early onset breast cancer without a family history. J Med Genet 37:792–794PubMedCrossRef

57.

Armes JE, Egan AJM, Southey MC et al (2000) The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations. Cancer 83:2335–2345CrossRef

58.

Swanson GM, Haslam SZ, Azzouz F (2002) Breast cancer among young African-American women. Cancer 97:273CrossRef

59.

Thadhani R, Stampfer MJ, Hunter DJ et al (1999) High body mass index and hypercholesterolemia risk of hypertensive disorders of pregnancy. Obstet Gynecol 94:543–550PubMedCrossRef

60.

Ghafoor A, Jemal A, Ward E et al (2009) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53:342–355CrossRef

61.

Cichowska A, Fischbacher CM, Brock A et al (2008) Early onset of breast cancer in British black women. Br J Cancer 98:2011 doi:10.1038/sj.bjc.6604416

62.

Cunningham JE, Montero AJ, Garrett-Mayer E et al (2010) Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status. Cancer Causes Control 21:399–409PubMedCrossRef

63.

Kurian AW, Fish K, Shema SJ et al (2010) Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res 12:R99PubMedCrossRef

64.

Clarke CA, Keegan TH, Yang J et al (2012) Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst 104:1094–1101PubMedCrossRef

Titel: Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: Are there differences before and after age 40?
verfasst von: Erica T. Warner
Graham A. Colditz
Julie R. Palmer
Ann H. Partridge
Bernard A. Rosner
Rulla M. Tamimi
Publikationsdatum: 01.11.2013
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 1/2013
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-013-2721-9

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: Are there differences before and after age 40?

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

Favorable modulation of benign breast tissue and serum risk biomarkers is associated with >10 % weight loss in postmenopausal women

Trastuzumab-related cardiac events in the treatment of early breast cancer

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model

MicroRNA signatures in hereditary breast cancer

Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie